Evidence map›Paper›PMID 30635032›Full record

ArticleArthritis research & therapy2019

Vitamin D protects podocytes from autoantibodies induced injury in lupus nephritis by reducing aberrant autophagy.

Qi Yu, Yingjin Qiao, Dongwei Liu, Fengxun Liu, Congcong Gao, Jiayu Duan, Lulu Liang, Xueqi Di, Yi Yuan, Yukui Gao and 5 more

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. The Role of Vitamin D in Autoimmune Diseases.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Lupus Nephritis from Pathogenesis to New Therapies: An Update.International journal of molecular sciences · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Vitamin D and Glomerulonephritis.Medicina (Kaunas, Lithuania) · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Qi YuDepartment of Nephrology, Research Institute of Nephrology, Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Core Unit of National Clinical Medical Research Center of Kidney Disease, The First Affiliated Hospital of Zhengzhou University, Nephrology, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Yingjin QiaoDepartment of Nephrology, Research Institute of Nephrology, Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Core Unit of National Clinical Medical Research Center of Kidney Disease, The First Affiliated Hospital of Zhengzhou University, Nephrology, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Dongwei LiuDepartment of Nephrology, Research Institute of Nephrology, Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Core Unit of National Clinical Medical Research Center of Kidney Disease, The First Affiliated Hospital of Zhengzhou University, Nephrology, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Fengxun LiuDepartment of Nephrology, Research Institute of Nephrology, Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Core Unit of National Clinical Medical Research Center of Kidney Disease, The First Affiliated Hospital of Zhengzhou University, Nephrology, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Congcong GaoDepartment of Rheumatology, The First Affiliated Hospital of Zhengzhou University, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Jiayu DuanDepartment of Nephrology, Research Institute of Nephrology, Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Core Unit of National Clinical Medical Research Center of Kidney Disease, The First Affiliated Hospital of Zhengzhou University, Nephrology, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Lulu LiangDepartment of Nephrology, Research Institute of Nephrology, Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Core Unit of National Clinical Medical Research Center of Kidney Disease, The First Affiliated Hospital of Zhengzhou University, Nephrology, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Xueqi DiDepartment of Rheumatology, The First Affiliated Hospital of Zhengzhou University, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Yi YuanDepartment of Nephrology, Research Institute of Nephrology, Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Core Unit of National Clinical Medical Research Center of Kidney Disease, The First Affiliated Hospital of Zhengzhou University, Nephrology, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Yukui GaoDepartment of Urology, The First Affiliated Hospital of Zhengzhou University, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Siwan CuiDepartment of Rheumatology, The First Affiliated Hospital of Zhengzhou University, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Yilu QinDepartment of Rheumatology, The First Affiliated Hospital of Zhengzhou University, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Tianfang LiDepartment of Rheumatology, The First Affiliated Hospital of Zhengzhou University, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China.
Zhaohui ZhengDepartment of Rheumatology, The First Affiliated Hospital of Zhengzhou University, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China. fcczhengzh@zzu.edu.cn.ORCID 0000-0003-3817-0171
Zhangsuo LiuDepartment of Nephrology, Research Institute of Nephrology, Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province, Core Unit of National Clinical Medical Research Center of Kidney Disease, The First Affiliated Hospital of Zhengzhou University, Nephrology, 1 Easten Jianshe Road, Zhengzhou, 450052, Henan, People's Republic of China. zhangsuoliu@zzu.edu.cn.
First Affiliated Hospital of Zhengzhou University · CN

Funding

Chinese national key research and development projects 2016YFC1305404Provincial Science Foundation of China 162300410273
6 · The paper itself

Abstract

subjectThe aim of this study was to investigate whether vitamin D plays a protective role in podocyte injury induced by autoantibodies purified from the serum of patients with lupus nephritis (LN) via reducing aberrant autophagy.

methodsAutophagic activities of renal tissues of patients with LN were evaluated under transmission electronic microscope (TEM). Immunoglobulin G (IgG) from patients with LN was purified to induce human podocyte injury, and the role of vitamin D in injury was observed. Podocytes were observed under TEM, autophagic activity was evaluated by western blot analysis and quantitative real-time polymerase chain reaction, and mRFP-GFP-LC3B adenovirus was infected into human podocytes in vitro.

resultsSignificantly higher autophagic levels were observed in patients with LN (P <0.05), and apparently greater autophagic levels in podocytes were shown (P <0.05). Among different classifications of LN, class V (n = 5), III + V (n = 5), and IV + V (n = 5) gained higher autophagic levels than class III (n = 5) and IV (n = 5). Induced autophagy, which was evident by increased LC3B-II and Beclin 1 level, caused consumption of p62, more autophagosomes observed under TEM, and more LC3B dots observed under confocal microscope in the IgG group, along with decreased nephrin expression, which suggests podocyte injury. Reduction of autophagy as well as alleviated podocyte injury was observed in the IgG+ vitamin D group.

conclusionThis study demonstrates that vitamin D plays a protective role in podocyte injury induced by autoantibodies from patients with LN and appears to be a novel therapy target in LN.

Indexed as

AdolescentAdultAutoantibodiesAutophagyCell Line, TransformedChildFemaleHumansLupus NephritisMaleMiddle AgedPodocytesVitamin DYoung AdultAutoantibodiesVitamin DAutophagyLupus nephritisPodocyteVitamin D

Identifiers

PMID30635032
PMCPMC6330406
OpenAlexW2911625058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.